Skip header and navigation

3 records – page 1 of 1.

Cigarette Smoke and Oxidative Stress

https://libcat.nshealth.ca/en/permalink/provcat29150
editors, Barry B. Halliwell, Henrik E. Poulsen. --Berlin, Heidelberg: Springer-Verlag , c2006.
Available Online
View e-Book
Location
Online
Available Online
View e-Book
Other Authors
Halliwell, Barry B.
Poulsen, Henrik E.
Responsibility
editors, Barry B. Halliwell, Henrik E. Poulsen
Place of Publication
Berlin, Heidelberg
Publisher
Springer-Verlag
Date of Publication
c2006
ISBN
9783540322320
Subjects (MeSH)
Tobacco Smoking - adverse effects
Tobacco Smoking - physiopathology
Oxidative Stress
Contents
1. Oxidative Stress -- 2. Tobacco Smoke Constituents Affecting Oxidative Stress -- 3. Oxidative Modifications of Proteins and Lipids by Cigarette Smoke (CS). A Central Role for Unsaturated Aldehydes in CS-Mediated Airway Inflammation -- 4. Cigarette Smoke-Induced Redox Signaling and Gene Expression in In Vitro and In Vivo Models -- 5. Redox Effects of Cigarette Smoke in Lung Inflammation -- 6. Oxidative Stress in the Pathogenesis of Chronic Obstructive Pulmonary Disease -- 7. Modulation of Cigarette Smoke Effects by Diet and Antioxidants -- 8. Modulation of Cigarette Smoke Effects by Antioxidants: Oxidative Stress and Degenerative Diseases -- 9. Smoking Depletes Vitamin C: Should Smokers Be Recommended to Take Supplements? -- 10. Experimental In Vitro Exposure Methods for Studying the Effects of Inhalable Compounds -- 11. Oxidative Stress in Laboratory Animals Exposed to Cigarette Smoke, with Special Reference to Chronic Obstructive Pulmonary Disease -- 12. Pulmonary Effects of Cigarette Smoke in Humans -- 13. Smoking and Oxidative Stress: Vascular Damage -- 14. Nrf2: a Transcription Factor that Modifies Susceptibility to Cigarette Smoke-Induced Pulmonary Oxidative Stress and Emphysema -- 15. Tobacco Smoke and Skin Aging -- 16. Cigarette Smoke and Oxidative DNA Modification.
Format
e-Book
Location
Online
Less detail

Smoking Prevention and Cessation

https://libcat.nshealth.ca/en/permalink/provcat40742
Giuseppe La Torre. --New York, NY: Springer , c2013.
Available Online
View e-Book
Location
Online
The cravings, the compulsive behaviors, the potential fatal health consequences--once considered relatively harmless, tobacco use is now understood to have addictive properties similar to those of hard drugs. Dependence on tobacco and nicotine from smoking, chewing, or other means affects millions around the world, and for countless people it remains resistant to efforts to quit despite the level of intervention or number of attempts. Smoking Prevention and Cessation addresses this longstanding…
Available Online
View e-Book
Author
La Torre, Giuseppe
Responsibility
Giuseppe La Torre
Place of Publication
New York, NY
Publisher
Springer
Date of Publication
c2013
Physical Description
1 online resource (viii, 478 p. : ill.)
ISBN
9781461470465
9781461470458 (print ed.)
Subjects (MeSH)
Smoking Cessation
Smoking Prevention
Tobacco Smoking - adverse effects
Tobacco Use Disorder - therapy
Abstract
The cravings, the compulsive behaviors, the potential fatal health consequences--once considered relatively harmless, tobacco use is now understood to have addictive properties similar to those of hard drugs. Dependence on tobacco and nicotine from smoking, chewing, or other means affects millions around the world, and for countless people it remains resistant to efforts to quit despite the level of intervention or number of attempts. Smoking Prevention and Cessation addresses this longstanding problem on various biological, societal, and psychological fronts. This extensively researched volume traces the mechanics of smoking initiation, nicotine dependence and withdrawal, and motivation to quit. Chapters analyze smoking as a global public health issue, review the epidemiology of smoking-related disease, and evaluate prevention and cessation interventions (pharmacology included) as applied to different settings and populations. The detailed, data-rich presentation gives readers a rounded, realistic understanding of smoking on a worldwide level as the book: Introduces measurement tools for gauging nicotine dependence; Examines the media in tobacco advertising and smoking prevention messages; Analyzes "what works" in prevention approaches; Compares the efficacy of cessation interventions; Pinpoints issues specific to smoking among health professionals and youth; Reviews economic, bioethics, and policy issues related to smoking. Researchers and graduate students in public health, health promotion, behavioral medicine, and smoking cessation will find Smoking Prevention and Cessation a unique reference packed with evidence-based insights and practical, workable ideas.
Contents
1. From nicotine dependence to motivation to stop smoking -- 1.1 Introduction: Denial and Delay -- 1.2 Tobacco and nicotine -- 1.2.1 What is Nicotine? -- 1.3 Addiction and Nicotine addiction -- 1.4 Nicotine withdrawal -- 1.5 How to measure nicotine dependence -- 1.5.1 Fagerstrom Tolerance Questionnaire -- 1.5.2 Fagerstrom Test for Nicotine Dependence -- 1.6 Motivation to stop smoking -- 2. State of the art of smoking habits in the world -- 2.1 Introduction: the tobacco epidemic -- 2.2 Data on incidence, prevalence, by gender, age-groups, ethnic groups -- 2.2.1 Tobacco consumption by gender and adults in the six major regions of the world -- 2.2.2 Tobacco consumption by adolescents in the six major regions of the world -- 2.2.3 Ethnic groups -- 2.3 Passive smoking -- 2.3.1 Secondhand smoking -- 2.3.2 Thirdhand smoking -- 3. Smoking-related diseases epidemiology -- 3.1 Introduction -- 3.2 Cardiovascular diseases -- 3.2.1 Coronary Heart Disease -- 3.2.2 Hypertension -- 3.2.3 Cerebro-Vascular Disease -- 3.2.4 Aortic Aneurism -- 3.3 Respiratory diseases -- 3.3.1 Chronic Obstructive Pulmonary Disease (COPD) -- 3.3.2 Chronic Bronchitis -- 3.3.3 Emphysema -- 3.3.4 Asthma -- 3.4 Cancers: main smoking-related cancers -- 3.4.1 Lung Cancer -- 3.4.2 Cancer of the Larynx -- 3.4.3 Cancer of the Oesophagus -- 3.4.4 Lower urinary tract -- 3.4.5 Pancreatic Cancer -- 3.4.6 Stomach Cancer -- 3.4.7 Breast Cancer -- 3.4 Other diseases -- 3.4.1 Acne -- 3.4.2 Low Birth Weight -- 3.4.3 Sudden Infant Death Syndrome (SIDS) -- 3.4.4. Maculophaty -- 3.4.5 Smoking related allergy -- 3.4.6 Early Menopause -- 4. Smoking-related cancer epidemiology -- 4.1 Introduction -- 4.2 Cancers: main smoking-related cancers -- 4.3 Lung Cancer -- 4.4 Cancer of the Larynx -- 4.5 Cancer of the Esophagus -- 4.6 Lower urinary tract -- 4.7 Pancreatic Cancer -- 4.8 Stomach Cancer -- 4.9 Breast Cancer -- 5. Classical determinants of smoking initiation -- 5.1 Introduction -- 5.2 The role of the family -- 5.3 The peer -- 5.3.1 Peer Socialization -- 5.3.2 Peer Selection -- 5.4 The society -- 5.5 Personal characteristics -- 6. Smoking prevention -- 6.1 Introduction: Smoking prevention at school -- 6.1.1.Data on incidence and prevalence among adolescents -- 6.1.2 Smoking prevention interventions at school -- 6.1.3 Community interventions -- 6.1.4 Evidence-based recommendations and guidelines -- 6.2 Smoking prevention in the workplace: Introduction -- 6.2.1 Data on incidence and prevalence among workers -- 6.2.2 Workplace interventions for smoking cessation -- 6.2.3 Smoking-free workplace legislation -- 6.3 Smoke free legislation -- 7. Smoking Prevention Through Mass Media Campaigns -- 7.1 Mass Media campaigns -- 7.1.1 Mass Media campaigns definition -- 7.1.2 The use of mass media campaigns in Public Health -- 7.1.3 Identifying the target audience -- 7.1.4 Characteristics of the message: design, contents, emotional appeal and source -- 7.1.5 Dissemination strategy and channelá characteristics -- 7.2 Mass Media campaigns in smoking prevention strategies -- 7.2.1 Formative research, theory and evaluation -- 7.2.2 Audience segmentation -- 7.2.3 Message appeal, contents, format and tone -- 7.2.4 Channel selection and message placement -- 7.3 Overview of the theoretical approaches of tobacco control mass media campaigns -- 7.3.1 Input-output persuasion model -- 7.3.2 Health beliefs model -- 7.3.3 Theory of reasoned action (Theory of planned behavior) -- 7.3.4 Integrative model of behavior change -- 7.3.5 Trans-theoretical model (or State of Changes) -- 7.3.6 Social learning (cognitive) theory (Bandura A. 1977) -- 7.4 Mass Media Campaigns: overview of scientific evidence -- 7.4.1 Overview of scientific literature -- 7.4.2 Effectiveness, opportunities and shortcomings of mass media campaigns in preventing smoking initiation -- 7.4.3 Characteristics of Effective Mass Media Campaigns -- 7.4.4 Expert conclusions on Mass Media Public Education Campaigns -- 7.4.5 Identified research gaps -- 7.5 Mass Media Campaigns: evidence into practice -- 7.5.1 Main umbrella organizations involved (e.g.WHO,EU. OECD) -- 7.5.2 The World Health Organization -- 7.5.3 The European community -- 7.5.4 Main National Public Health Agencies, including guidance/best practices delivery agencies -- 7.6 Smoking Prevention: Mass Media campaigns worldwide -- 7.6.1 Worldwide Mass Media campaigns targeted at general population and at specific demographic groups -- 8. How to tackle smoking at the population level -- 8.1 The Tobacco free Framework -- 8.2 EU legislation on tobacco -- 8.3 Package advertising -- 9. Smoking among health professionals -- 9.1 Introduction -- 9.2 Smoking among Medical doctors -- 9.3 Smoking Prevalence among Nurses -- 9.4 Public awareness about smoking habits among Health Professionals -- 9.5 Smoking among health profession students -- 10. Basic principles of smoking cessation techniques -- 10.1 Introduction -- 10.2 Transtheoretical approach Model (TTM) -- 10.2.1 Precontemplation -- 10.2.2 Contemplation.-10.2.3 Preparation -- 10.2.4 Action -- 10.2.5 Maintenance -- 10.3 What is counseling? -- 10.3.1 Counseling for Smoking Cessation -- 10.3.2 Administrative aspects of counseling -- 10.4 The 5 As and 3As approaches -- 10.4.1 5A's -- 10.4.2 3A's -- 10.5 The evidence of counseling -- 10.6 Medication for drug cessation -- 10.6.1 First-line medications -- 10.6.1.1 Nicotine Replacement Medications -- 10.6.1.2 Products not containing Nicotine -- 10.6.1.3 The evidence of efficacy of first-line medications -- 11. Smoking cessation among different settings -- 11.1 Smoking cessation in the general population -- 11.2 Smoking cessation in the clinical setting -- 11.3 Smoking cessation in the workplace -- 11.4 Smoking cessation among healthcare professionals -- 11.4.1 Introduction -- 11.4.2 The key role of health care providers in smoking cessation -- 11.4.3 Prevalence of tobacco consumption among health care professionals -- 11.4.4 Implementation of smoking cessation strategies: a review of current scientific literature -- 11.4.5 Compared efficacy of various smoking cessation interventions -- 11.4.6 Conclusions -- 12. Media and Smoking Cessation -- 12.1 Introduction -- 12.2 The Allen Carr book on "How to quit smoking" -- 12.3 Information on the Web -- 12.4 Web-based courses -- 13. Ethical aspects of tobacco smoking -- 13.1 Tobacco- smoking and public awareness : What Are the Risks? -- 13.1.1 Tobacco is not just killing smokers -- 13.1.2 Do Smokers Voluntarily Accept the Risks? -- 13.2 Individual rights -- 13.2.1 Types and importance of individual rights: public health and other perspectives -- 13.2.2 Human Rights -- 13.2.3 Assumption: the Concept of "Public Health" -- 13.3 Bioethical basis for global tobacco control -- 13.3.2 Principles of bioethics -- 13.3.3 Political outcomes -- 13.3.4 Legal Paternalism, Nanny-statism, and the Defense of Public Health against Environmental Tobacco Smoke -- 13.3.5 Social action: Is there a 'right' to advertise? -- 13.3.6 Tobacco taxation and public health: ethical problems, policy responses -- 13.3.7 Restrictions on smoking in public places -- 13.3.8 Education, information and physician's responsibility in promoting the patient's health in the community, strongly supported by ethical arguments grounded in medical professionalism -- 13.4 Burden of disease attributable to tobacco use and Tobacco-related costs -- 14. Economic issues related to tobacco smoking -- 14.1 Production and supply of tobacco products -- 14.1.1 Growing and manufacturing tobacco -- 14.1.2 The costs of production -- 14.1.3 Tobacco growing and manufacturing external effects -- 14.1.4 Production policies -- 14.2 Selling strategies and demand of tobacco products -- 14.2.1 Models of demand for tobacco products -- 14.2.2 Imperfectly rational addiction models -- 14.2.3 Myopic rational addiction models -- 14.2.4 Rational addiction -- 14.2.5 Behavioral models -- 14.2.6 Policy issues: prices, taxation and incentives -- 14.2.7 Advertising -- 14.2.8 Market diversification and emerging markets -- 14.3 Caring for smoking related illnesses.
Format
e-Book
Location
Online
Less detail

Tobacco or Health? : Physiological and Social Damages Caused by Tobacco Smoking

https://libcat.nshealth.ca/en/permalink/provcat29956
Knut-Olaf Haustein, David Groneberg. (2nd ed.) --Berlin, Heidelberg: Springer , c2010.
Available Online
View e-Book
Location
Online
Available Online
View e-Book
Author
Haustein, Knut-Olaf
Other Authors
Groneberg, David
Responsibility
Knut-Olaf Haustein, David Groneberg
Edition
2nd ed.
Place of Publication
Berlin, Heidelberg
Publisher
Springer
Date of Publication
c2010
ISBN
9783540875772
Subjects (MeSH)
Nicotine - pharmacology
Socioeconomic Factors
Tobacco Smoking - adverse effects
Tobacco Use Disorder - therapy
Contents
1. History of Tobacco -- 2. Epidemiology of Tobacco Dependence -- 3. Tobacco Constituents and Additives -- 4. Pharmacology and Pharmacokinetics of Nicotine -- 5. Smoking and Lung Disease -- 6. Cardiovascular Disease, Disturbances of Blood Coagulation and Fibrinolysis -- 7. Other Organ Systems -- 8. Smoking and Pregnancy -- 9. Passive Smoking -- 10. Non-Drug Treatments to Promote Smoking Cessation -- 11. Pharmacotherapy of Nicotine Dependence -- 12. Primary Prevention -- 13. Tobacco Industry, Advertising and Advertising Bans -- 14. Society, Politics and the Tobacco Industry -- 15. Appendix: Experiences from a Smoker Counselling Centre.
Format
e-Book
Location
Online
Less detail